Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Phase 3RecruitingNCT03949049

Sherief Abd-Elsalam40 enrolled

Overview

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Efficacy of Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Citacoline as neuroprotector

placebo group

Sex: ALLMax age: 1 Month

Medical Language ↔ Plain English

Inclusion Criteria: * neonates with hypoxia. Exclusion Criteria: * hypoxic ischemic encephalopathy

Sherief Abd-Elsalam

Cairo, Egypt

RECRUITING

number of seizures

Time frame: 6 months

sherief abd-elsalam, ass. prof.

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.